ArticleOncoimmunology2015
Myeloid
Open access · goldAbstract read
In one paragraph
Article in Oncoimmunology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 28 citations in OpenAlex.
- EGFR deletion in myeloid cells reprograms the immunosuppressive landscape of colorectal cancer.Cell death and differentiation · 2026Article
- Inhibiting SLAMF8 modulates tumor-associated macrophages and restores CD8+ T cell-mediated antitumor immunity in colorectal cancer.Oncoimmunology · 2025Article
- Advances in molecular mechanisms of inflammatory bowel disease‑associated colorectal cancer (Review).Oncology letters · 2024Review
- A subpopulation of CD146Cellular & molecular immunology · 2023Article
- Myeloid FTH1 Deficiency Protects Mice From Colitis and Colitis-associated Colorectal Cancer via Reducing DMT1-Imported Iron and STAT3 Activation.Inflammatory bowel diseases · 2023Article
- Article
- Targeting STAT3 Signaling in COL1+ Fibroblasts Controls Colitis-Associated Cancer in Mice.Cancers · 2022Article
- Review
- Meta-Analysis of Microdissected Breast Tumors Reveals Genes Regulated in the Stroma but Hidden in Bulk Analysis.Cancers · 2021Article
- Lipid Metabolism and Cancer Immunotherapy: Immunosuppressive Myeloid Cells at the Crossroad.International journal of molecular sciences · 2020Review
- IDO1Communications biology · 2020Article
- Immunotherapy Targeting Tumor-Associated Macrophages.Frontiers in medicine · 2020Review
- LPS Enhances the Chemosensitivity of Oxaliplatin in HT29 Cells via GSDMD-Mediated Pyroptosis.Cancer management and research · 2020Article
- JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factors.Proceedings of the National Academy of Sciences of the United States of America · 2019Article
- Cancer-induced inflammation and inflammation-induced cancer in colon: a role for S1P lyase.Oncogene · 2019Article
- Trained Immunity for Personalized Cancer Immunotherapy: Current Knowledge and Future Opportunities.Frontiers in microbiology · 2019Review
- Inflammation and Colorectal Cancer.Current colorectal cancer reports · 2017Article
- EGFR in Tumor-Associated Myeloid Cells Promotes Development of Colorectal Cancer in Mice and Associates With Outcomes of Patients.Gastroenterology · 2017Article
- STAT3 inhibition for cancer therapy: Cell-autonomous effects only?Oncoimmunology · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
23 authors at 9 institutions in 7 countries.
Paulina PathriaInstitute for Cancer Research; Medical University Vienna & Comprehensive Cancer Center (CCC) ; Vienna, Austria.
Dagmar GotthardtInstitute for Pharmacology and Toxicology; University of Veterinary Medicine Vienna; Austria.
Michaela Prchal-MurphyInstitute for Pharmacology and Toxicology; University of Veterinary Medicine Vienna; Austria.
Eva-Maria PutzInstitute for Pharmacology and Toxicology; University of Veterinary Medicine Vienna; Austria.
Martin HolcmannInstitute for Cancer Research; Medical University Vienna & Comprehensive Cancer Center (CCC) ; Vienna, Austria.
Michaela SchledererLudwig Boltzmann Institute for Cancer Research LBICR; Vienna, Austria; Institute of Clinical Pathology; Medical University of Vienna; Vienna, Austria; Unit of Pathology of Laboratory Animals; University of Veterinary Medicine Vienna ; Vienna, Austria.
Beatrice GrabnerLudwig Boltzmann Institute for Cancer Research LBICR; Vienna, Austria; Institute of Clinical Pathology; Medical University of Vienna; Vienna, Austria; Unit of Pathology of Laboratory Animals; University of Veterinary Medicine Vienna ; Vienna, Austria.
Ilija CrncecInstitute for Cancer Research; Medical University Vienna & Comprehensive Cancer Center (CCC) ; Vienna, Austria.
Jasmin SvinkaInstitute for Cancer Research; Medical University Vienna & Comprehensive Cancer Center (CCC) ; Vienna, Austria.
Monica MusteanuSpanish National Cancer Research Centre (CNIO) ; Madrid, Spain.
Thomas HoffmannInstitute of Molecular Pathology IMP ; Vienna, Austria.
Martin FilipitsInstitute for Cancer Research; Medical University Vienna & Comprehensive Cancer Center (CCC) ; Vienna, Austria.
Walter BergerInstitute for Cancer Research; Medical University Vienna & Comprehensive Cancer Center (CCC) ; Vienna, Austria.
Valeria PoliDepartment of Molecular Biotechnology and Health Sciences; Molecular Biotechnology Center; University of Turin ; Italy.
Lukas KennerLudwig Boltzmann Institute for Cancer Research LBICR; Vienna, Austria; Institute of Clinical Pathology; Medical University of Vienna; Vienna, Austria; Unit of Pathology of Laboratory Animals; University of Veterinary Medicine Vienna ; Vienna, Austria.
Martin BilbanMedical University Vienna; Department of Medical and Chemical Laboratory Diagnostics ; Vienna, Austria ;
Emilio CasanovaLudwig Boltzmann Institute for Cancer Research LBICR; Vienna, Austria; Institute of Clinical Pathology; Medical University of Vienna; Vienna, Austria; Unit of Pathology of Laboratory Animals; University of Veterinary Medicine Vienna ; Vienna, Austria.
Mathias MüllerInstitute of Animal Breeding and Genetics; University of Veterinary Medicine Vienna ; Vienna, Austria.
Birgit StroblInstitute of Animal Breeding and Genetics; University of Veterinary Medicine Vienna ; Vienna, Austria.
Editha BayerInstitute for Cancer Research; Medical University Vienna & Comprehensive Cancer Center (CCC) ; Vienna, Austria.
Thomas MohrInstitute for Cancer Research; Medical University Vienna & Comprehensive Cancer Center (CCC) ; Vienna, Austria.
Veronika SexlInstitute for Pharmacology and Toxicology; University of Veterinary Medicine Vienna; Austria.
Robert EferlInstitute for Cancer Research; Medical University Vienna & Comprehensive Cancer Center (CCC) ; Vienna, Austria.
Comprehensive Cancer Center Vienna · ATUniversity of Veterinary Medicine Vienna · ATInstitute of Laboratory Animal Science · CNAll-Russian Research Institute of Genetics and Farm Animal Breeding · RULudwig Boltzmann Institute for Cancer Research · ATMedical University of Vienna · ATResearch Institute of Molecular Pathology · ATSpanish National Cancer Research Centre · ESUniversity of Turin · IT
Funding
Austrian Science Fund FWF P 25599
Abstract
Myeloid cells lacking
Indexed as
AOM, Azoxymethane, CRC, colorectal cancerDSS, DextransulfateIHC, immunohistochemistryimmune surveillanceimmunoeditingSTAT3, signal transducer and activator of transcription 3TAM, tumor-associated macrophagetumor microenvironmenttumor stroma
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.